[Therapy of senile dementia of the Alzheimer type and multi-infarct dementia].
D000544:Alzheimer Disease / Q000473:pathology / Q000628:therapy*; D000818:Animals; D001921:Brain / Q000473:pathology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003131:Combined Modality Therapy; D003704:Dementia / Q000473:pathology / Q000628:therapy*; D003866:Depressive Disorder / Q000628:therapy; D004088:Dihydroergotoxine / Q000627:therapeutic use; D004311:Double-Blind Method; D004734:Energy Metabolism / Q000187:drug effects; D006801:Humans; D002504:Meclofenoxate / Q000627:therapeutic use; D018377:Neurotransmitter Agents / Q000378:metabolism; D010889:Piracetam / Q000627:therapeutic use; D011613:Psychotherapy / Q000379:methods; D011746:Pyrithioxin / Q000627:therapeutic use
D018377:Neurotransmitter Agents; D004088:Dihydroergotoxine; D011746:Pyrithioxin; D002504:Meclofenoxate; D010889:Piracetam
Die Therapie der senilen Demenz vom Alzheimer-Typ und der Multi-Infarkt-Demenz.